Skip to main content

Formoterol / mometasone Pregnancy and Breastfeeding Warnings

Brand names: Dulera

Medically reviewed by Drugs.com. Last updated on Feb 5, 2024.

Formoterol / mometasone Pregnancy Warnings

This drug should be used during pregnancy only if the benefit outweighs the risk to the fetus.

US FDA pregnancy category: C

Animal studies have shown teratogenicity at higher than clinically used doses. In these studies, mometasone and formoterol were administered separately. There are no controlled data in human pregnancy.

US FDA pregnancy category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.

See references

Formoterol / mometasone Breastfeeding Warnings

Caution is recommended.

Excreted into human milk: Unknown (formoterol, mometasone)
Excreted into animal milk: Data not available (mometasone); Yes (formoterol)

Comments: The effects in the nursing infant are unknown.

Studies of formoterol in rats have shown excretion in breast milk.

See references

See also

References for pregnancy information

  1. (2010) "Product Information. Dulera (formoterol-mometasone)." Schering-Plough Corporation

References for breastfeeding information

  1. (2010) "Product Information. Dulera (formoterol-mometasone)." Schering-Plough Corporation

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer